Your browser is no longer supported. Please, upgrade your browser.
ImmunoPrecise Antibodies Ltd.
Index- P/E- EPS (ttm)- Insider Own6.73% Shs Outstand19.08M Perf Week-19.17%
Market Cap127.07M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float17.07M Perf Month9.18%
Income- PEG- EPS next Q- Inst Own7.21% Short Float0.79% Perf Quarter-27.84%
Sales17.18M P/S7.40 EPS this Y- Inst Trans- Short Ratio0.06 Perf Half Y-59.19%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year22.20%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range5.00 - 33.34 Perf YTD-55.45%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-79.06% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low39.60% ATR1.21
Employees- Current Ratio- Sales Q/Q11.90% Oper. Margin- RSI (14)50.42 Volatility11.68% 16.75%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.80 Prev Close6.66
ShortableYes LT Debt/Eq- EarningsJul 28 AMC Payout- Avg Volume2.23M Price6.98
Recom- SMA205.83% SMA501.66% SMA200-30.19% Volume848,543 Change4.80%
Jul-28-21 08:02AM  
Jul-22-21 08:02AM  
Jul-20-21 04:53AM  
Jul-15-21 08:08AM  
Jun-22-21 08:28AM  
Jun-17-21 08:28AM  
Jun-15-21 08:28AM  
Jun-02-21 09:05PM  
May-25-21 08:28AM  
May-20-21 07:28AM  
Apr-21-21 08:28AM  
Apr-08-21 08:02AM  
Mar-25-21 09:03AM  
Mar-17-21 06:48PM  
Mar-16-21 07:29AM  
Mar-04-21 07:28AM  
Feb-19-21 07:28AM  
Feb-13-21 01:25AM  
Feb-10-21 06:54PM  
Feb-08-21 04:01PM  
Feb-03-21 10:50PM  
Jan-18-21 07:44AM  
Jan-06-21 10:34PM  
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in the antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune and naive phage display production and screening; hybridoma production with screening and clone-picking; transgenic animals and multi-species antibody discovery; antibody characterization studies, such as affinity measurements, functional assays and epitope mapping, and binning; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA synthesis and cloning, protein and antibody downstream processing; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; and cryopreservation. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.